CO : Summary for China Cord Blood Corporation Co - Yahoo Finance

U.S. Markets closed

China Cord Blood Corporation (CO)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
5.83-0.05 (-0.85%)
At close: 4:02PM EST
People also watch
CCMCXDCNPDCBPOCPHI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close5.88
Open5.85
Bid0.00 x
Ask0.00 x
Day's Range5.75 - 5.91
52 Week Range4.27 - 6.43
Volume81,137
Avg. Volume117,904
Market Cap466.89M
Beta0.62
PE Ratio (TTM)32.39
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire18 days ago

    China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement

    HONG KONG, Jan. 4, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic ...

  • PR Newswire18 days ago

    China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement

    HONG KONG, Jan. 4, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic ...

  • PR Newswire23 days ago

    Golden Meditech to Sell its equity Interest in China Cord Blood Corporation for Cash Consideration of RMB5.764 Billion

    HONG KONG, Dec. 30, 2016 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, announces that it entered into a sale and purchase agreement with Nanjing Yingpeng Huikang Medical Industry Investment Partnership (Limited Partnership) 1 ("Yingpeng Huikang Fund" or the "Purchaser") on 30 December 2016 regarding the disposal of the Company's entire equity stake in China Cord Blood Corporation ("CCBC") which represents 65.4% equity interest in CCBC on a fully diluted basis, for total cash consideration of RMB5.764 billion.